InsidersTradesSigma
Browse the full record of transactions filed by Lenington Rachel, 首席运营官. Insider active across 1 company, notably Athira Pharma, Inc.. Aggregated, 1 disclosures have been recorded. History available since 22 June 2022. The latest transaction was disclosed on 22 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Rachel Lenington serves as the Chief Operating Officer at Athira Pharma, Inc. In this role, she is responsible for managing the company's daily operations. Athira Pharma, Inc. is a biopharmaceutical company focused on developing innovative treatments. Rachel leverages her expertise to optimize operational efficiency and support the company's strategic objectives.